Circulating levels of active but not total TGF beta 1 are reduced in early diffuse cutaneous systemic sclerosis
Magdalena Dziadzio, CP Denton(The Royal Free Hospital), Carla Fonseca, Dietmar Abraham(Medical University of Vienna), GE Lindahl, Russell Smith(International Centre for Diarrhoeal Disease Research), Casilda G. Black
UCL Discovery (University College London)
March 1, 2005
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
|Journal of Biological Chemistry|2000|219
Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate
|European Neurology|2008|99
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
|Annals of the Rheumatic Diseases|2006|98